Trial Profile
Phase II study of sildenafil citrate in Waldenstrom's macroglobulinemia.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Jun 2011
Price :
$35
*
At a glance
- Drugs Sildenafil (Primary)
- Indications Waldenstrom's macroglobulinaemia
- Focus Therapeutic Use
- 23 Jun 2011 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
- 20 Dec 2007 Status changed from in prgoress to discontinued.
- 06 Oct 2006 Status change